Seattle, WA — March 3, 2026 — Pacific Northwest Research Institute (PNRI), an independent nonprofit biomedical research institute founded in 1956 and based in Seattle’s First Hill neighborhood, today announced the sale of its research building as part of a strategic effort to strengthen its financial foundation and sustain its scientific mission. The transaction is intended to generate operating cash flow and enhance flexibility to support world-class research.
As part of the transaction, PNRI will lease back space in the building to ensure continuity of its laboratory and research operations. The institute’s scientific work will continue uninterrupted in the same location it has occupied for decades.

“Scientific discovery requires both vision and resilience. This transaction strengthens our financial footing, provides near-term stability, and gives us the flexibility to plan boldly for the future.”
Mark Rieder, PhD
PNRI Chief Operating Officer
The six-story property has served as PNRI’s research home since 1988, housing laboratory, office, and meeting space. Its location along the Broadway corridor places it within one of Seattle’s most active life sciences and medical districts. The property will seek additional tenants in space not occupied by PNRI.
“Scientific discovery requires both vision and resilience,” said Mark Rieder, PhD, Chief Executive Officer of PNRI. “This transaction strengthens our financial footing, provides near-term stability, and gives us the flexibility to plan boldly for the future.”
The building sale enables PNRI to concentrate resources on advancing discoveries in genetics and human health while remaining an active contributor to Seattle’s dynamic biomedical ecosystem.
About Pacific Northwest Research Institute (PNRI)
Pacific Northwest Research Institute (PNRI), founded in 1956, is an independent, nonprofit biomedical research institute dedicated to solving some of the most pressing questions in genetics and human health. PNRI scientists collaborate with partners locally, nationally, and globally to better understand and treat rare and common diseases alike.
Media Contact:
Louise Maxwell
Pacific Northwest Research Institute
lmaxwell@pnri.org

